Cristina de Andrade Monteiro

Dr. Cristina de Andrade Monteiro

Departamento de Biologia, Instituto Federal do Maranhão, São Luís, Maranhão, Brazil
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
GSGiselle C. de Oliveira Santos
Giselle C. de Oliveira Santos
CVCleydlenne Costa Vasconcelos
Cleydlenne Costa Vasconcelos
ALBERTO JORGE OLIVEIRA LOPESALBERTO JORGE OLIVEIRA LOPES
ALBERTO JORGE OLIVEIRA LOPES
MCMaria Do S. de Sousa Cartágenes
Maria Do S. de Sousa Cartágenes
AFAllan K. D. B. Filho
Allan K. D. B. Filho
Cristina de Andrade MonteiroCristina de Andrade Monteiro
Cristina de Andrade Monteiro
The Candida genus comprises opportunistic fungi that can become pathogenic when the immune system of the host fails. Candida albicans is the most important and prevalent species. Polyenes, fluoropyrimidines, echinocandins, and azoles are used as commercial antifungal agents to treat candidiasis. However, the presence of intrinsic and developed resistance against azole antifungals has been extensively documented among several Candida species. The advent of original and re-emergence of classical fungal diseases have occurred as a consequence of the development of the antifungal resistance phenomenon. In this way, the development of new satisfactory therapy for fungal diseases persists as a major challenge of present-day medicine. The design of original drugs from traditional medicines provides new promises in the modern clinic. The urgent need includes the development of alternative drugs that are more efficient and tolerant than those traditional already in use. The identification of new substances with potential antifungal effect at low concentrations or in combination is also a possibility. The present review briefly examines the infections caused by Candida species and focuses on the mechanisms of action associated with the traditional agents used to treat those infections, as well as the current understanding of the molecular basis of resistance development in these fungal species. In addition, this review describes some of the promising alternative molecules and/or substances that could be used as anticandidal agents, their mechanisms of action, and their use in combination with traditional drugs.

10 April 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
ATAnalucia G. Terças
Analucia G. Terças
AMAndrea de Souza Monteiro
Andrea de Souza Monteiro
EMEduardo B. Moffa
Eduardo B. Moffa
JSJulliana R. A. dos Santos
Julliana R. A. dos Santos
ESEduardo M. de Sousa
Eduardo M. de Sousa
Cristina de Andrade MonteiroCristina de Andrade Monteiro
Cristina de Andrade Monteiro
Terminalia catappa Linn bark is used to treat dysentery by various populations in Southeast Asian countries, and its leaves have also been used in traditional medicine to treat hepatitis in India and the Philippines. Here, the antifungal actions of crude hydro-alcoholic extract (TcHE) and fractions from T. catappa leaves were assessed via the agar diffusion and microdilution tests on Candida reference strains and clinical isolates from patients with acquired immunodeficiency syndrome (AIDS). Additionally, the potential cytotoxic effects of TcHE were assessed on cultured human peripheral blood mononuclear cells (PBMC). T. catappa fractions and sub-fractions were analyzed by gas chromatography coupled to mass spectrometry with electron impact (GC/MS/EI), high-performance liquid chromatography coupled to mass spectrometry "electrospray" ionization in positive mode (HPLC/MS/MS/ESI+) and hydrogen nuclear magnetic resonance (1HNMR). TcHE and its fractions were able to inhibit the growth of all tested Candida strains with the n-butanol (FBuOH) fraction presenting the best antifungal activity. Testing of different FBuOH sub-fractions (SF) showed that SF10 was the most active against Candida spp. Fractioning of SF10 demonstrated that 5 out of its 15 sub-fractions were active against Candida spp., with SF10.5 presenting the highest activity. Chemical analysis of SF10 detected hydrolysable tannins (punicalin, punicalagin), gallic acid and flavonoid C-glycosides. Overall, the results showed that T. catappa L. leaf extract, fractions and sub-fractions were antifungal against Candida spp. and may be useful to treat diseases caused by this fungus.

1 January 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MSMércia H.S.L. Souza
Mércia H.S.L. Souza
Cristina de Andrade MonteiroCristina de Andrade Monteiro
Cristina de Andrade Monteiro
PFPatricia M.S. Figueredo
Patricia M.S. Figueredo
FNFlávia Raquel Fernandes Nascimento
Flávia Raquel Fernandes Nascimento
RGRosane N.M. Guerra
Rosane N.M. Guerra

12 September 2019 in Pathogens
Verified
Journal Article
Open access
PDF file
CSCamilla Santos
Camilla Santos
YFYasmine Ramos França
Yasmine Ramos França
CCCarmem Duarte Lima Campos
Carmem Duarte Lima Campos
MARIA ROSA BOMFIMMARIA ROSA BOMFIM
MARIA ROSA BOMFIM
BMBruna Oliveira Melo
Bruna Oliveira Melo
Valério Monteiro-NetoValério Monteiro-Neto
Valério Monteiro-Neto
Candida yeasts are generally found in the vaginal microbiota; however, disruption of the balance maintained by host factors and microorganisms results in vulvovaginal candidiasis (VVC). This study evaluated the antagonistic activity of vaginal Lactobacillus spp. on Candida albicans to verify whether active compounds of Lactobacillus spp. had antifungal and antivirulence activity. The antagonism assay showed that 15 out of 20 Lactobacillus strains had an inhibitory effect on C. albicans. Biosurfactants displayed surface-tension-reducing activity, with the best value obtained for Lactobacillus gasseri 1. Lactobacillus rhamnosus ATCC 9595, Lactobacillus acidophilus ATCC 4356, and Lactobacillus paracasei 11 produced biosurfactants that decreased C. albicans adhesion and disrupted biofilm formation. The best results were obtained in the pre-incubation assay for L. gasseri 1 and L. paracasei 11. Overall, Lactobacillus strains showed significant anti-Candida activity, and their biosurfactants exhibited considerable anti-adhesion and antibiofilm activity against C. albicans. To be considered safe for use in vivo, the safety of biosurfactant (BS) should be investigated using cytotoxicity assays.

10 June 2011 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
AJAurean D'Eça Júnior
Aurean D'Eça Júnior
ASAnderson França Silva
Anderson França Silva
FRFernanda Costa Rosa
Fernanda Costa Rosa
Silvio Gomes MonteiroSilvio Gomes Monteiro
Silvio Gomes Monteiro
PFPatrícia de Maria Silva Figueiredo
Patrícia de Maria Silva Figueiredo
Cristina de Andrade MonteiroCristina de Andrade Monteiro
Cristina de Andrade Monteiro
INTRODUCTION: Candida yeasts are commensals; however, if the balance of normal flora is disrupted or the immune defenses are compromised, Candida species can cause disease manifestations. Several attributes contribute to the virulence and pathogenicity of Candida, including the production of extracellular hydrolytic enzymes, particularly phospholipase and proteinase. This study aimed to investigate the in vitro activity of phospholipases and acid proteinases in clinical isolates of Candida spp. METHODS: Eighty-two isolates from hospitalized patients collected from various sites of origin were analyzed. Phospholipase production was performed in egg yolk medium and the production of proteinase was verified in a medium containing bovine serum albumin. The study was performed in triplicate. RESULTS: Fifty-six (68.3%) of isolates tested were phospholipase positive and 16 (44.4%) were positive for proteinase activity. C. tropicalis was the species with the highest number of positive isolates for phospholipase (91.7%). Statistically significant differences were observed in relation to production of phospholipases among species (p<0,0001) and among the strains from different sites of origin (p=0.014). Regarding the production of acid protease, the isolates of C. parapsilosis tested presented a larger number of producers (69.2%). Among the species analyzed, the percentage of protease producing isolates did not differ statistically (χ2=1.9 p=0.5901 (χ2=1.9 p=0.5901). CONCLUSIONS: The majority of C. non-albicans and all C. albicans isolates were great producers of hydrolytic enzymes and, consequently, might be able to cause infection under favorable conditions.

2 March 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
ATAna L. G. Terças
Ana L. G. Terças
SMSirlei G. Marques
Sirlei G. Marques
EMEduardo B. Moffa
Eduardo B. Moffa
MAMárcia B. Alves
Márcia B. Alves
CAConceição M. P. S. de Azevedo
Conceição M. P. S. de Azevedo
Cristina de Andrade MonteiroCristina de Andrade Monteiro
Cristina de Andrade Monteiro
Oropharyngeal candidiasis is the most common fungal infection in hospitalized patients with acquired immune deficiency syndrome (AIDS). Its progression results in invasive infections, which are a significant cause of morbidity and mortality. This study aimed to quickly and accurately identify Candida spp. from oral mucosa of AIDS patients recruited at Presidente Vargas Hospital, in São Luís city, Maranhão, Brasil and to evaluate the sensitivity profile of these fungi to antifungals by using an automated system. Isolates were collected from oropharyngeal mucosa of 52 hospitalized AIDS patients, under anti-viral and antifungal therapies. Patients were included in research if they were HIV-positive, above 18 years of age and after obtaining their written consent. CHROMagar®Candida and the automated ViteK-2®system were used to isolate and identify Candida spp, respectively. Antifungal susceptibility testing was performed using the ViteK-2®system, complemented with the E-test®, using the drugs amphotericin B, fluconazole, flucytosine, and voriconazole. Oropharyngeal candidiasis had a high prevalence in these hospitalized AIDS patients (83%), and the most prevalent species was Candida albicans (56%). Antifungal susceptibility test showed that 64.7% of the Candida spp. were susceptible, 11.8% were dose-dependent sensitive, and 23.5% were resistant. All the Candida krusei and Candida famata isolates and two of Candida glabrata were resistant to fluconazole. Most of AIDS patients presented oropharyngeal candidiasis and C. albicans was the most frequently isolated species. The results showed high variability in resistance among isolated species and indicates the need to identify the Candida spp. involved in the infection and the need to test antifungal susceptibility as a guide in drug therapy in patients hospitalized with AIDS. This is the first relate about AIDS patients monitoring in a public hospital in São Luís concerning the precise identification and establishing of antifungal profile of Candida spp.